Tty Biopharm
Tty Biopharm Corporation, commonly referred to as Tty Biopharm, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Taiwan (TW). Established in 1965, the company has made significant strides in developing innovative pharmaceutical products, particularly in the fields of oncology and chronic disease management.
With a strong presence in both domestic and international markets, Tty Biopharm is recognised for its commitment to quality and research-driven solutions. The company’s core offerings include a diverse range of generic and proprietary medications, distinguished by their efficacy and safety profiles. Tty Biopharm's dedication to advancing healthcare has positioned it as a leader in the pharmaceutical sector, earning accolades for its contributions to patient care and therapeutic advancements.
-5 vs industry average
Tty Biopharm’s score of 33 is lower than 47% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Tty Biopharm?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Tty Biopharm's reported carbon emissions
Tty Biopharm, a pharmaceutical preparation manufacturing company headquartered in TW, has reported its carbon emissions across various scopes.
For the most recent reporting year, 2024, Tty Biopharm's total calculated emissions were approximately 12.5 million kg CO2e. This figure comprises Scope 1 emissions of about 1.9 million kg CO2e, Scope 2 emissions of approximately 8.1 million kg CO2e, and Scope 3 emissions of around 2.5 million kg CO2e.
In 2023, the company reported total calculated emissions of approximately 12.7 million kg CO2e, with Scope 1 at about 1.7 million kg CO2e, Scope 2 at approximately 8.5 million kg CO2e, and Scope 3 at around 2.5 million kg CO2e.
Historical data shows that in 2022, Tty Biopharm's total calculated emissions were approximately 12.8 million kg CO2e. This included Scope 1 emissions of about 1.5 million kg CO2e, Scope 2 emissions of approximately 8.2 million kg CO2e, and Scope 3 emissions of roughly 3 million kg CO2e.
Prior to 2022, the company's reporting primarily focused on Scope 1 and Scope 2 emissions. For instance, in 2021, Scope 1 emissions were approximately 925,000 kg CO2e, and Scope 2 emissions were about 6.9 million kg CO2e. In 2020, Scope 1 emissions were around 953,000 kg CO2e, and Scope 2 emissions were approximately 7.7 million kg CO2e. In 2019, Scope 1 emissions were about 977,000 kg CO2e, and Scope 2 emissions were approximately 7.2 million kg CO2e. In 2018, combined Scope 1 and Scope 2 emissions were approximately 15.5 million kg CO2e. In 2017, total emissions were approximately 8.2 million kg CO2e, with Scope 1 at about 756,000 kg CO2e and Scope 2 at approximately 4.2 million kg CO2e. In 2016, Scope 3 emissions, specifically purchased goods and services, were reported at 625,000 kg CO2e.
Tty Biopharm has not publicly disclosed specific reduction targets or commitments from the provided reduction initiatives data. The company does provide GHG emission intensity figures per unit of revenue in its sustainability reports, indicating a focus on efficiency.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Tty Biopharm’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Tty Biopharm yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project